In fiscal year 2023, Aurobindo Pharma's net debt to EBITDA ratio was negative 0.33, down from fiscal year 2020. The net profit of the pharmaceutical company before taxes was over 19 billion Indian rupees in financial year 2023.
Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Zoetis
Overview
4
- Premium Statistic Global animal health market 2002-2021
- Basic Statistic Distribution of global animal health care market by species 2021
- Premium Statistic Direct and indirect economic impact of animal health industry in the U.S. 2021
- Basic Statistic Economic performance per worker in the U.S. animal health industry 2021, by indicator
Revenue figures
4
Revenue distribution
4
Competitors
4
Other key data
5
Further related statistics
9
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Further Content: You might find this interesting as well
Statistics
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- Net earnings of UnitedHealth Group 2007-2023
- Total assets of UnitedHealth Group 2007-2023
- Foreign exchange earnings from tourism in India 2000-2022
- Number of international tourist arrivals in India 2010-2021
- International tourism receipts of India 2011-2022
- Rate of new cases of tuberculosis in the U.S. 1960-2019
- New cases of Lyme disease in the U.S. 1991-2019
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
Aurobindo Pharma. (August 1, 2023). Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023 [Graph]. In Statista. Retrieved June 10, 2024, from https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/
Aurobindo Pharma. "Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023." Chart. August 1, 2023. Statista. Accessed June 10, 2024. https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/
Aurobindo Pharma. (2023). Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023. Statista. Statista Inc.. Accessed: June 10, 2024. https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/
Aurobindo Pharma. "Net Debt to Ebitda Ratio of Aurobindo Pharma Limited from Financial Year 2013 to 2023." Statista, Statista Inc., 1 Aug 2023, https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/
Aurobindo Pharma, Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023 Statista, https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/ (last visited June 10, 2024)
Net debt to EBITDA ratio of Aurobindo Pharma Limited from financial year 2013 to 2023 [Graph], Aurobindo Pharma, August 1, 2023. [Online]. Available: https://internal.statista.com/statistics/996079/india-aurobindo-pharma-net-debt-ebitda-ratio/